Patent Applications published on May 15, 2025 - page 4

#901
US20250152538A1
Human necessities

METHOD FOR TREATING A DISORDER

#902
US20250152539A1
Human necessities

LEVODOPA DOSING REGIMEN

#903
US20250152540A1
Human necessities

LEVODOPA DOSING REGIMEN

#904 ✅ Patent 12,303,482 granted on 2025-05-20
US20250152541A1
Human necessities

Levodopa dosing regimen

#905
US20250152542A1
Human necessities

LEVODOPA DOSING REGIMEN

#906 ✅ Patent 12,370,163 granted on 2025-07-29
US20250152543A1
Human necessities

LEVODOPA DOSING REGIMEN

#907 ✅ Patent 12,324,796 granted on 2025-06-10
US20250152544A1
Human necessities

SLEEP-IMPROVING COMPOSITIONS AND METHODS OF USE

#908
US20250152545A1
Human necessities

NOVEL ANTIVIRAL COMPOSITIONS COMPRISING OLEIC ACID

#909
US20250152546A1
Human necessities

MODIFIED RELEASE GAMMA-HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS

#910
US20250152547A1
Human necessities

COMPOSITIONS FOR DELIVERY OF LADOSTIGIL

#911
US20250152548A1
Human necessities

METHODS OF PROVIDING SOLRIAMFETOL THERAPY TO SUBJECTS WITH IMPAIRED RENAL FUNCTION

#912
US20250152549A1
Human necessities

METHOD OF TREATING CONDITIONS RELATED TO THE PGI2 RECEPTOR

#913
US20250152550A1
Human necessities

LYMPH-TARGETING FORMULATIONS

#914
US20250152551A1
Human necessities

DOCETAXEL COMPOSITIONS AND METHODS

#915
US20250152552A1
Human necessities

CANCER-CELL PROLIFERATION INHIBITOR AND CANCER-CELL-PROLIFERATION INHIBITION ENHANCER

#916
US20250152553A1
Human necessities

CARBAMOTHIOATE, AND CARBAMODITHIOATE DERIVATIVES OF MDMA, MDA OR ITS OPTICALLY ACTIVE (R)- OR (S)-MDMA AND MDA ISOMERS

#917
US20250152554A1
Human necessities

ORALLY ADMINISTRABLE COMPOSITIONS COMPRISING AVOCADO/SOYBEAN UNSAPONIFIABLES AND LIPOIC ACID AND METHODS OF ADMINISTRATION

#918
US20250152555A1
Human necessities

Pharmaceutical Composition for Preventing or Treating Triple-Negative Breast Cancer

#919
US20250152556A1
Human necessities

ETRASIMOD FOR USE IN TREATING S1P1 RECEPTOR-ASSOCIATED DISORDERS IN COMBINATION WITH HORMONE TREATMENT

#920
US20250152557A1
Human necessities

METHODS FOR TREATING SUBJECTS WITH ABDOMINAL OBESITY HYPERTRIGLYCERIDEMIA AND/OR IMPAIRED GLUCOSE

#921
US20250152558A1
Human necessities

STABLE PHARMACEUTICAL COMPOSITIONS OF CLONIDINE

#922
US20250152559A1
Human necessities

METHODS FOR TREATING MYC-AMPLIFIED CANCER

#923
US20250152560A1
Human necessities

HDAC INHIBITOR OKI-179 IN COMBINATION WITH BINIMETINIB FOR THE TREATMENT OF CANCER

#924
US20250152561A1
Human necessities

METHODS AND COMPOSITIONS RELATED TO SYNTHETIC NANOCARRIERS WITH RAPAMYCIN IN A STABLE, SUPER-SATURATED STATE

#925
US20250152562A1
Human necessities

Compositions to Enhance and Extend Quality of Life

#926
US20250152563A1
Human necessities

BIOMARKERS FOR NANOPARTICLE COMPOSITIONS

#927
US20250152564A1
Human necessities

PROPYLENE KETONE-CONTAINING BIOINHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF

#928
US20250152565A1
Human necessities

EFFECTS OF LYSERGIC ACID DIETHYLAMIDE (LSD) AND OF LSD ANALOGS TO ASSIST PSYCHOTHERAPY FOR GENERALIZED ANXIETY DISORDER OR OTHER ANXIETY NOT RELATED TO LIFE-THREATENING ILLNESS

#929
US20250152566A1
Human necessities

USE OF AMINOPYRIDINE, IN PARTICULAR AMIFAMPRIDINE, FOR THE TREATMENT OF A VIRALLY-ASSOCIATED FATIGUE

#930
US20250152567A1
Human necessities

COMPOUNDS FOR USE IN THE TREATMENT OF DYSTROPHINOPATHIES

#931
US20250152568A1
Human necessities

METHODS OF TREATING COMPLEX REGIONAL PAIN SYNDROME

#932
US20250152569A1
Human necessities

TREATMENT OF CELL PROLIFERATION-ASSOCIATED CONDITIONS USING A COMBINATION OF A CLB-B INHIBITOR AND AN ADDITIONAL THERAPEUTIC AGENT

#933
US20250152570A1
Human necessities

Uses of Selonsertib in the Preparation of Drugs for the Treatment of Cancer

#934
US20250152571A1
Human necessities

PHARMACEUTICAL COMPOSITION OF ANTIPLATELET DRUG, AND USE THEREOF

#935
US20250152572A1
Human necessities

NICOTINE FORMULATION

#936
US20250152573A1
Human necessities

ORAL COMPOSITIONS WITH REDUCED WATER CONTENT

#937
US20250152574A1
Human necessities

EMOPAMIL-BINDING PROTEIN INHIBITORS AND USES THEREOF

#938
US20250152575A1
Human necessities

METHODS FOR TREATING IMMUNODEFICIENCY DISEASE

#939
US20250152576A1
Human necessities

INJECTABLE FORMULATION COMPRISING ISOXAZOLINE DERIVATIVE AND METHOD FOR PREPARING SAME

#940
US20250152577A1
Human necessities

Pharmaceutical Composition of Ethidium Bromide and Use in Treating Cancer

#941
US20250152578A1
Human necessities

Stabilizing Camptothecin Pharmaceutical Compositions

#942
US20250152579A1
Human necessities

Diketopiperazine Microparticles with Defined Specific Surface Areas

#943
US20250152580A1
Human necessities

METHODS FOR TREATING IMMUNE DISEASES

#944
US20250152581A1
Human necessities

METHODS OF TREATING NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY USING MODIFIED FORMS OF TRIMETAZIDINE

#945
US20250152582A1
Human necessities

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIVE BCL-2 INHIBITOR

#946
US20250152583A1
Human necessities

AMILORIDE FOR USE IN THE TOPICAL TREATMENT OF SOMATOSENSORY IMPAIRMENTS

#947
US20250152584A1
Human necessities

NLRP3 INFLAMMASOME INHIBITOR AND USES THEREOF

#948
US20250152585A1
Human necessities

PHARMACEUTICAL COMPOUND

#949
US20250152586A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR RELIEVING OR TREATING PAIN BY REGULATING CEREBELLAR GLIAL CELLS AND METHOD FOR RELIEVING OR TREATING PAIN

#950
US20250152587A1
Human necessities

PLATINUM-RESISTANT CANCER TREATMENT

#951
US20250152588A1
Human necessities

HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS

#952
US20250152589A1
Human necessities

THERAPEUTIC OR PREVENTIVE AGENT FOR EYE DISEASES

#953
US20250152590A1
Human necessities

NURR1:RXR ACTIVATING COMPOUNDS FOR SIMULTANEOUS TREATMENT OF SYMPTOMS AND PATHOLOGY OF PARKINSON'S DISEASE

#954
US20250152591A1
Human necessities

TREATMENT OF HEMATOLOGICAL MALIGNANCIES WITH MENIN INHIBITORS AND P-GLYCOPROTEIN INHIBITORS

#955
US20250152592A1
Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING ALLOPURINOL, FEBUXOSTAT OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR PREVENTION OR TREATMENT OF CHRONIC KIDNEY DISEASE IN SUBJECT HAVING HIGH SERUM URIC ACID CONCENTRATION

#956
US20250152593A1
Human necessities

p38 MAPK INHIBITORS AND USES THEREOF

#957
US20250152594A1
Human necessities

ORAL SOLID TABLET COMPRISING BRUTON'S TYROSINE KINASE INHIBITOR AND PREPARATION METHOD THEREFOR

#958
US20250152595A1
Human necessities

MEDICATION TO ALLEVIATE NAUSEA WITH OR WITHOUT VOMITING, VERTIGO, AND PAIN

#959
US20250152596A1
Human necessities

METHOD OF TREATING PAIN OR INTERSTITIAL CYSTITIS USING INDOLE COMPOUND

#960
US20250152597A1
Human necessities

LINEZOLID FORMULATIONS

#961
US20250152598A1
Human necessities

METHOD FOR TREATING CANCER

#962
US20250152599A1
Human necessities

ANTI-CORONAVIRUS EFFECT AND APPLICATION OF P14K INHIBITOR

#963
US20250152600A1
Human necessities

BROMODOMAIN INHIBITORS

#964
US20250152601A1
Human necessities

Compositions and Methods for the Treatment of Sexual Dysfunctions

#965
US20250152602A1
Human necessities

MODULATION OF AVERSIVE AND SALT TASTES

#966
US20250152603A1
Human necessities

NEFOPAM DOSAGE FORMS AND METHODS OF TREATMENT

#967
US20250152604A1
Human necessities

CONTRACEPTIVE METHODS WITH SCHEDULED BLEEDING EFFECTS

#968
US20250152605A1
Human necessities

METHOD AND DRUG FOR TREATING NEURONAL CEROID LIPOFUSCINOSIS

#969
US20250152606A1
Human necessities

INDUCTION OF IRREVERSIBLE INFERTILITY IN FEMALE MAMMALIAN ANIMALS USING A SINGLE PROGESTERONE IMPLANT

#970
US20250152607A1
Human necessities

COMPOSITIONS FOR VITAMIN D PRODUCTION

#971
US20250152608A1
Human necessities

CONTRACEPTIVE METHODS WITH IMPROVED PEARL INDEX

#972
US20250152609A1
Human necessities

SALICYLIC ACID COMPOSITIONS AND USES THEREOF

#973
US20250152610A1
Human necessities

IMIDAZOLATE GOLD COMPOUNDS FOR THE TREATMENT OF LUNG CANCER

#974
US20250152611A1
Human necessities

IMMUNOMODULATORY LIPIDS AND USES THEREOF

#975
US20250152612A1
Human necessities

POLYPEPTIDE COUPLED BORON CARRYING AGENT, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL FORMULATION

#976
US20250152613A1
Human necessities

COMPOSITIONS AND METHODS FOR COVID-19 TREATMENT

#977
US20250152614A1
Human necessities

Compositions And Methods For Inducing Apoptosis In Anaerobic Cells And Related Clinical Methods For Treating Cancer And Pathogenic Infections

#978
US20250152615A1
Human necessities

GEMCITABINE LIPOSOME PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF

#979
US20250152616A1
Human necessities

COMPOSITIONS FOR AND METHODS OF TREATING, PREVENTING, AND/OR MITIGATING PAIN

#980
US20250152617A1
Human necessities

PHARMACEUTICAL COMPOSITION CONTAINING STIMULANT FOR PWAR5 EXPRESSION AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING INFECTIOUS DISEASES DUE TO HEPATITIS C VIRUS

#981
US20250152618A1
Human necessities

ANTIVIRAL SULFATED CHITOSAN DERIVATIVES

#982
US20250152619A1
Human necessities

POLYIMIDAZOLIUM-BASED CATIONIC ANTIMICROBIAL POLYMERS FOR NOVEL MASTITIS PROPHYLACTIC SOLUTIONS

#983
US20250152620A1
Human necessities

PROPHYLAXIS AND THERAPY FOR OCULAR DISEASES LEADING TO BLINDNESS

#984
US20250152621A1
Human necessities

A NON-SWALLOWED, ANTACID CHEWING GUM PRODUCT, A PROCESS FOR ITS PREPARATION AND USES THEREOF

#985
US20250152622A1
Human necessities

ALUMINUM-MANGANESE COMPOSITE NANOCRYSTAL, AND PREPARATION METHOD THEREFOR AND USE THEREOF

#986
US20250152623A1
Human necessities

Compositions and kits for use in wound healing, tissue regeneration and/or bone regeneration

#987
US20250152624A1
Human necessities

COMPOSITIONS AND METHODS OF TREATMENT FOR CANCERS

#988
US20250152625A1
Human necessities

CELLS AND METHODS

#989
US20250152626A1
Human necessities

CONSTRUCTION AND APPLICATION OF ENHANCED NEUTROPHIL DRUG

#990
US20250152627A1
Human necessities

COMPOSITIONS AND METHODS FOR ENHANCING IMMUNE CELL FUNCTION USING MODIFIED CELLS WITH GLYCOCALYX EDITING ENZYMES

#991
US20250152628A1
Human necessities

TCR TARGETING CYTOMEGALOVIRUS ANTIGEN, T CELL EXPRESSING TCR, AND APPLICATION

#992
US20250152629A1
Human necessities

COMPOSITIONS INCLUDING KILLER INNATE-LIKE T CELLS AND USES THEREOF

#993
US20250152630A1
Human necessities

METHODS FOR THE PRODUCTION OF TCR GAMMA DELTA + T CELLS

#994
US20250152631A1
Human necessities

SYNNOTCH RECEPTOR AND USE THEREOF

#995
US20250152632A1
Human necessities

RENAL CELL POPULATIONS AND USES THEREOF

#996
US20250152633A1
Human necessities

CELLS HAVING IMPROVED PROLIFERATIVE CAPACITY AND REDUCED CELLULAR SENESCENCE

#997
US20250152634A1
Human necessities

METHOD FOR ENHANCING EXPRESSION OF INSULIN LIKE GROWTH FACTOR 1 RECEPTOR IN UMBILICAL CORD MESENCHYMAL STEM CELL AND METHOD FOR OBTAINING MULTIPOTENT UMBILICAL CORD MESENCHYMAL STEM CELL

#998
US20250152635A1
Human necessities

BONE AUGMENTATION UTILIZING MUSCLE-DERIVED PROGENITOR COMPOSITIONS, AND TREATMENTS THEREOF

#999
US20250152636A1
Human necessities

CARDIAC STEM CELLS FOR CARDIAC REPAIR

#1000
US20250152637A1
Human necessities

AKKERMANSIA FOR PREVENTING AND/OR TREATING REWARD DYSREGULATION DISORDERS

#1001
US20250152638A1
Human necessities

AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE GASTROINTESTINAL SYSTEM

#1002
US20250152639A1
Human necessities

OVARIAN CARE FORMULA CONTAINING A-SDGPLUS AND PREPARATION METHOD THEREFOR

#1003
US20250152640A1
Human necessities

MICROORGANISMS WITH REDUCED COMPETENCE

#1004
US20250152641A1
Human necessities

LACTOBACILLUS PARACASEI NB23 STRAIN AND METHOD OF USING THE SAME TO INCREASE MUSCLE MASS AND TO PREVENT/TREAT METABOLIC SYNDROME

#1005
US20250152642A1
Human necessities

NASAL ANTI-CANCER THERAPIES

#1006
US20250152643A1
Human necessities

COMBINATIONS OF CHECKPOINT INHIBITORS AND ONCOLYTIC VIRUS FOR TREATING CANCER

#1007
US20250152644A1
Human necessities

RECOMBINANT ONCOLYTIC VIRUS AND USE THEREOF

#1008
US20250152645A1
Human necessities

SINGLE CELL PROTEIN PRODUCTS

#1009
US20250152646A1
Human necessities

SOLVENTS, METHODS, AND SYSTEMS FOR ISOLATING CANNABINOIDS FROM PLANTS EXTRACTS OR FROM SYNTHETIC PATHWAYS

#1010
US20250152647A1
Human necessities

FORMULATIONS AND METHODS FOR SKIN CARE

#1011
US20250152648A1
Human necessities

SYSTEM AND METHOD OF PROCESSING HEMP FOR EXTRACTION OF SELECT COMPONENTS THEREOF

#1012
US20250152649A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR USE IN INCREASING HAIR, MODIFYING SCALP OR SKIN, HEALING A WOUND, PROMOTING OSTEOGENESIS, OR MODIFYING HAIR

#1013
US20250152650A1
Human necessities

COMPOSITIONS FOR TREATING SEA LICE IN SALMON AND RELATED METHODS

#1014
US20250152651A1
Human necessities

COMPOSITIONS AND METHODS FOR EXTRACTING COMPOUNDS

#1015
US20250152652A1
Human necessities

PHARMACEUTICAL COMPOSITION, PHYTOMEDICINE, KIT, PROCESS FOR PREPARING A PHARMACEUTICAL COMPOSITION, AND, USES OF ESSENTIAL OIL AND/OR A PHARMACEUTICAL COMPOSITION

#1016
US20250152653A1
Human necessities

ASHWAGANDHA EXTRACTS AND FORMULATIONS THEREOF

#1017
US20250152654A1
Human necessities

COMBINATION, COMPOSITION, AND METHOD OF ADMINISTERING THE COMBINATION OR COMPOSITION TO ANIMALS

#1018
US20250152655A1
Human necessities

EDIBLE PLANT-DERIVED NANOPARTICLES FOR REGULATION OF GUT MICROBIOTA

#1019
US20250152656A1
Human necessities

INHIBITION OF TREM RECEPTOR SIGNALING WITH PEPTIDE VARIANTS

#1020
US20250152657A1
Human necessities

COMPOSITION FOR PROMOTING HAIR GROWTH, PHARMACEUTICAL COMPOSITION FOR PROMOTING HAIR GROWTH COMPRISING THE COMPOSITION, AND METHOD FOR PROMOTING HAIR GROWTH BY USING THE SAME

#1021
US20250152658A1
Human necessities

CYCLIC PEPTIDE FOR TRAPPING INTERLEUKIN-1 BETA

#1022
US20250152659A1
Human necessities

METHOD FOR PREVENTING OR TREATING PARKINSON'S DISEASE

#1023
US20250152660A1
Human necessities

SCO-spondin-derived polypeptides for treating biological barriers dysfunction

#1024
US20250152661A1
Human necessities

NOVEL COMBINATION TREATMENT REGIMEN OF BACTERIAL INFECTIONS

#1025
US20250152662A1
Human necessities

METHODS OF TREATING A CYTOKINE STORM RELATED DISEASE WITH RECOMBINANT MUTATED HUMAN ANGIOPOIETIN-LIKE 4

#1026
US20250152663A1
Human necessities

COMPOSITION FOR PREVENTION OR TREATMENT OF DRY EYE DISEASE COMPRISING HAPLN1

#1027
US20250152664A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISORDERS

#1028
US20250152665A1
Human necessities

Mutant Peptides And Methods Of Treating Subjects Using The Same

#1029
US20250152666A1
Human necessities

COMPLEXES FOR TREATING SENSITIVITY

#1030
US20250152667A1
Human necessities

SAP FC FUSION PROTEINS AND METHODS OF USE

#1031
US20250152668A1
Human necessities

PROTEIN FOR TREATMENT OF INFLAMMATORY DISEASES

#1032
US20250152669A1
Human necessities

Use of a VEGF Antagonist to Treat Angiogenic Eye Disorders

#1033
US20250152670A1
Human necessities

METHOD FOR ALLEVIATING PULMONARY FIBROSIS USING EPIDERMAL GROWTH FACTOR

#1034
US20250152671A1
Human necessities

MEDICAL COMPOSITION FOR TREATING PATIENTS EXHIBITING CARDIAC DECOMPENSATION

#1035
US20250152672A1
Human necessities

SEMAGLUTIDE FOR USE IN MEDICINE

#1036
US20250152673A1
Human necessities

PHARMACEUTICAL FORMULATIONS

#1037
US20250152674A1
Human necessities

ORAL OCTREOTIDE FOR TREATMENT OF DISEASE

#1038
US20250152675A1
Human necessities

I-TYPE RECOMBINANT COLLAGEN WITH HIGH TRANSDERMAL ABSORBABILITY, AND USE THEREOF

#1039
US20250152676A1
Human necessities

METHOD AND PHARMACEUTICAL COMPOSITION FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE

#1040
US20250152677A1
Human necessities

TREATMENT OF LIVER CANCERS BY DISRUPTING THE BETA-CATENIN/TCF-4 BINDING SITE LOCATED UPSTREATM OF MEG3 IN THE DLK1/DIO3 LOCUS

#1041
US20250152678A1
Human necessities

PROTEOLYTIC ENZYME COMPOSITION

#1042
US20250152679A1
Human necessities

DYSTROPHIN GENE EXON DELETION USING ENGINEERED NUCLEASES

#1043
US20250152680A1
Human necessities

COMPOSITIONS COMPRISING GLUCOCEREBROCIDASE AND METHODS OF USE THEREOF

#1044
US20250152681A1
Human necessities

NANODISC COMPRISING ANGIOTENSIN CONVERTING ENZYME 2

#1045
US20250152682A1
Human necessities

LIQUID BOTULINUM TOXIN FORMULATION AND USE THEREOF

#1046
US20250152683A1
Human necessities

PROCESSES FOR PRODUCING COMPOSITIONS WITH IMPROVED SAFETY PROFILE HAVING LIPASE ACTIVITY AND COMPOSITIONS SUITABLE FOR PHARMACEUTICAL USE

#1047
US20250152684A1
Human necessities

Anti-Alpha-Synuclein Therapeutic Vaccines

#1048
US20250152685A1
Human necessities

METHOD OF MAKING A PERSONALIZED CANCER VACCINE

#1049
US20250152686A1
Human necessities

IL-15-BASED FUSIONS TO IL-12 AND IL-18

#1050
US20250152687A1
Human necessities

CONSENSUS SEQUENCE OF THE ANTIGEN TELOMERASE AND THE USE THEREOF IN PREVENTIVE AND THERAPEUTIC VACCINATION

#1051
US20250152688A1
Human necessities

A Conjugate

#1052
US20250152689A1
Human necessities

VACCINE AGAINST LEPTOSPIROSIS

#1053
US20250152690A1
Human necessities

NOVEL LIVE MULTI-ANTIGENIC RECOMBINANT VACCINE AGAINST TUBERCULOSIS

#1054
US20250152691A1
Human necessities

IMMUNOGENIC COMPOSITION FOR PARATUBERCULOSIS

#1055
US20250152692A1
Human necessities

IMMUNOGENS TARGETING ANTHRAX

#1056
US20250152693A1
Human necessities

Neisseria Meningitidis Vaccine

#1057
US20250152694A1
Human necessities

METHODS AND COMPOSITIONS FOR MULTIVALENT VACCINES

#1058
US20250152695A1
Human necessities

AFRICAN SWINE FEVER VACCINE COMPOSITION

#1059
US20250152696A1
Human necessities

METHODS AND COMPOSITIONS FOR VACCINATION AGAINST HETEROSUBTYPIC INFLUENZA VIRUSES USING AN ADENOVIRAL VECTOR LEADING TO ENHANCED T CELL RESPONSE THROUGH AUTOPHAGY

#1060
US20250152697A1
Human necessities

AUTOLOGOUS CELL BASED SARS-COV-2 VACCINES

#1061
US20250152698A1
Human necessities

DNA ADJUVANT HYDROGEL-BASED PEPTIDE VACCINE, AND PREPARATION METHOD AND USE THEREOF

#1062
US20250152699A1
Human necessities

CORONAVIRUS VACCINE

#1063
US20250152700A1
Human necessities

ALUMINUM NANOCRYSTAL DELIVERY SYSTEM, AND SELF-ASSEMBLED PARTICLE ADJUVANT VACCINE BASED ON BINDING OF ALUMINUM NANOCRYSTAL DELIVERY SYSTEM AND VACCINE ANTIGEN MOLECULE

#1064
US20250152701A1
Human necessities

NKT CELL LIGAND-CONTAINING LIPOSOME COMPOSITION

#1065
US20250152702A1
Human necessities

EPICHAPEROME INHIBITION TO IMPROVE T CELL RESPONSES

#1066
US20250152703A1
Human necessities

COMPOSITIONS FOR STIMULATION OF MAMMALIAN INNATE IMMUNE RESISTANCE TO PATHOGENS

#1067
US20250152704A1
Human necessities

FCRN ANTAGONISTS WITH IMPROVED HALF-LIFE AND METHODS OF USE

#1068
US20250152705A1
Human necessities

COMBINATION THERAPY COMPRISING AN ANTI-IL-23 ANTIBODY AND A CORTICOSTEROID FOR TREATING PSORIASIS

#1069
US20250152706A1
Human necessities

COMPOSITIONS FOR ORAL DELIVERY OF BIOTHERAPEUTICS

#1070
US20250152707A1
Human necessities

CD70 COMBINATION THERAPY

#1071
US20250152708A1
Human necessities

COMPOSITIONS COMPRISING AN ANTI-LAG-3 ANTIBODY OR AN ANTI-LAG-3 ANTIBODY AND AN ANTI-PD-1 OR ANTI-PD-L1 ANTIBODY

#1072
US20250152709A1
Human necessities

CD3-TARGETED LENTIVIRAL VECTORS AND USES THEREOF

#1073
US20250152710A1
Human necessities

MODIFIED PRIMARY IMMUNE CELLS FOR INDUCTION OR ENHANCEMENT OF IMMUNOTHERAPY

#1074
US20250152711A1
Human necessities

COMPOSITIONS AND METHODS FOR MODULATING THE IMMUNE SYSTEM

#1075
US20250152712A1
Human necessities

METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY

#1076
US20250152713A1
Human necessities

MULTICHAIN ANTIGEN-SPECIFIC RECEPTORS FOR CELL-BASED IMMUNOTHERAPY

#1077
US20250152714A1
Human necessities

MIGRATORY MODIFIED DIFFERENTIATED B CELLS FOR CANCER THERAPY

#1078
US20250152715A1
Human necessities

COMPOSITIONS COMPRISING NKG2D, CXCR2, AND DAP10/DAP12 FUSION POLYPEPTIDES AND METHODS OF USE THEREOF

#1079
US20250152716A1
Human necessities

IMPROVED PRIMARY HUMAN NK CELL EXPANSION AND FUNCTION BY CHIMERIC CYTOKINE RECEPTOR

#1080
US20250152717A1
Human necessities

BINDING PROTEINS AND ENGINEERED CELLS SPECIFIC FOR NEOANTIGENS AND USES THEREOF

#1081
US20250152718A1
Human necessities

NUCLEIC ACID DELIVERY MATERIAL

#1082
US20250152719A1
Human necessities

FUSED IMIDE DERIVATIVE

#1083
US20250152720A1
Human necessities

NEW CARBOHYDRATE DERIVATIVES AS MIMETICS OF BLOOD GROUP A AND B ANTIGENS

#1084
US20250152721A1
Human necessities

PHARMACEUTICAL COMPOSITION CONTAINING PEGYLATED EXENATIDE VARIANT AND USE THEREOF

#1085
US20250152722A1
Human necessities

DRUG CONJUGATE OF GLUCOCORTICOID

#1086
US20250152723A1
Human necessities

ANTIBODY-DRUG CONJUGATES INVOLVING ERIANIN AND THE FABRICATION METHODS AND APPLICATIONS THEREOF

#1087
US20250152724A1
Human necessities

ANTIBODY CONJUGATES SPECIFIC FOR MUCIN-1 AND METHODS OF USE THEREOF

#1088
US20250152725A1
Human necessities

COMBINATION THERAPY WITH AN ANTI-AXL ANTIBODY-PBD CONJUGATE AND NANOCUPS

#1089
US20250152726A1
Human necessities

NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF

#1090
US20250152727A1
Human necessities

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

#1091
US20250152728A1
Human necessities

Method And Molecules

#1092
US20250152729A1
Human necessities

IMMUNOTHERAPY FOR CANCER

#1093
US20250152730A1
Human necessities

ANTI-TM4SF1 ANTIBODY-DRUG CONJUGATES COMPRISING CLEAVABLE LINKERS AND METHODS OF USING SAME

#1094
US20250152731A1
Human necessities

ANTI-TROP2 ANTIBODY COMBINATION THERAPIES AND METHODS OF USE THEREOF

#1095
US20250152732A1
Human necessities

ANTIBODY-BOUND LIPID NANOPARTICLE COMPRISING ANTIBODY BOUND TO MEMBRANE SCAFFOLD PROTEIN

#1096
US20250152733A1
Human necessities

ANTIBIOTIC AMPHIPHILIC NANOPARTICLE AND METHODS OF USING THE SAME AGAINST GRAM-NEGATIVE AND/OR GRAM-POSITIVE BACTERIA

#1097
US20250152734A1
Human necessities

USES AND FORMULATIONS OF CAMPTOTHECIN (CPT)-CONTAINING NANOPARTICLES

#1098
US20250152735A1
Human necessities

Lipid Nanoparticle Compositions and Methods for mRNA Delivery

#1099
US20250152736A1
Human necessities

IMMUNE SYSTEM MODULATORS AND USES THEREOF

#1100
US20250152737A1
Human necessities

LIPID NANOPARTICLES COMPRISING VENEZUELAN EQUINE ENCEPHALITIS (VEE) REPLICON AND USES THEREOF

#1101
US20250152738A1
Human necessities

GPR17 PROMOTER-BASED TARGETING AND TRANSDUCTION OF GLIAL PROGENITOR CELLS

#1102
US20250152739A1
Human necessities

COMPOSITION AND METHODS FOR TREATMENT OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY

#1103
US20250152740A1
Human necessities

MATERIALS AND METHODS FOR THE TREATMENT OF LIMB GIRDLE MUSCULAR DYSTROPHY

#1104
US20250152741A1
Human necessities

NUCLEIC ACID CONSTRUCTS ENCODING A CELL PENETRATING PEPTIDE, SIGNAL SEQUENCE AND TRANSCRIPTION FACTOR EB AND USES THEREOF

#1105
US20250152742A1
Human necessities

COMPOSITIONS AND METHODS FOR NEUROLOGICAL DISEASES

#1106
US20250152743A1
Human necessities

SYNPOPTOSIS CIRCUITS FOR PROGRAMMABLE CELL DEATH CONTROL

#1107
US20250152744A1
Human necessities

METHODS OF TREATING NEURODEGENERATIVE DISORDERS

#1108
US20250152745A1
Human necessities

NUCLEIC ACID COMPRISING OR CODING FOR A HISTONE STEM-LOOP AND A POLY(A) SEQUENCE OR A POLYADENYLATION SIGNAL FOR INCREASING THE EXPRESSION OF AN ENCODED PROTEIN

#1109
US20250152746A1
Human necessities

BASE EDITING OF ANGPTL3 AND METHODS OF USING SAME FOR TREATMENT OF DISEASE

#1110
US20250152747A1
Human necessities

METHODS OF TREATING GAUCHER DISEASE AND GBA-PARKINSON’S DISEASE

#1111
US20250152748A1
Human necessities

HYDRODYNAMIC GENE DELIVERY

#1112
US20250152749A1
Human necessities

ASSESSMENT OF ADVERSE EVENTS INDUCED BY ADMINISTRATION OF ANTITUMOR DRUG AND/OR IMMUNE CHECKPOINT INHIBITOR BY USING DISEASE MODEL MOUSE

#1113
US20250152750A1
Human necessities

CYANINE DYE NANOPARTICLES FOR SENESCENCE IMAGING

#1114
US20250152751A1
Human necessities

RED-SHIFTED FLUOROPHORES AND METHODS OF USING THE SAME

#1115
US20250152752A1
Human necessities

NEAR-INFRARED FLUORESCENT QUANTUM DOT FOR ACHIEVING RAPID RENAL CLEARANCE, AND PREPARATION METHOD AND APPLICATION THEREOF

#1116
US20250152753A1
Human necessities

FORMULATION OF CONTRAST MEDIA AND PROCESS OF PREPARATION THEREOF

#1117
US20250152754A1
Human necessities

MICROBUBBLE LYOPHILIZED PREPARATION FOR ULTRASONIC RADIOGRAPHY, CONTRAST AGENT, AND PREPARATION METHOD

#1118
US20250152755A1
Human necessities

SYSTEMS AND METHODS OF GENERATING LIPID, PROTEIN, AND/OR PROTEIN SHELLED BUBBLES

#1119
US20250152756A1
Human necessities

SURFACE MODIFICATION OF MICRO-BUBBLES AND NANOPARTICLES BASED ON POLY(ALKYLCYANOACRYLATE)

#1120
US20250152757A1
Human necessities

Radiopharmaceutical Compositions of Radioactive Halogenated Benzylguandine

#1121
US20250152758A1
Human necessities

PROBE FOR NUCLEAR MEDICAL TESTING

#1122
US20250152759A1
Human necessities

SINGLE-DOMAIN ANTIBODIES AND VARIANTS THEREOF AGAINST MET

#1123
US20250152760A1
Human necessities

RADIOACTIVE COMPLEX OF ANTI-VEGF ANTIBODY, AND RADIOPHARMACEUTICAL

#1124
US20250152761A1
Human necessities

MULTIFUNCTIONAL ULTRASONIC CLEANING DEVICE

#1125
US20250152762A1
Human necessities

INTERMITTENT CATHETER STORAGE/STERILIZATION/WARMING

#1126
US20250152763A1
Human necessities

INTERMITTENT CATHETER STORAGE/STERILISATION

#1127
US20250152764A1
Human necessities

INTERMITTENT CATHETER STORAGE/STERILISATION

#1128
US20250152765A1
Human necessities

DEVICE AND METHOD FOR THE GENERATION, CONTROL, AND APPLICATION OF HYDROGEN PEROXIDE VAPOR DOSE

#1129
US20250152766A1
Human necessities

CONTROL ENGINE, SYSTEM AND METHOD FOR CONTROLLING ONE OR MORE UV-C LIGHT SOURCES

#1130
US20250152767A1
Human necessities

CONTAINER FOR SANITIZING APPLICATIONS CONFIGURED TO SECURE A pH SENSITIVE COLOR INDICATOR

#1131
US20250152768A1
Human necessities

SCENT CONTROL ACCORDING TO LOCAL CONDITIONS OF A SCENT CONTROL DEVICE

#1132
US20250152769A1
Human necessities

AROMA PROVIDING DEVICE

#1133
US20250152770A1
Human necessities

GRAVITY-FED VOLATILE LIQUID AIR FRESHENING SYSTEMS

#1134
US20250152771A1
Human necessities

ABSORBENT ANTIMICROBIAL WOUND DRESSINGS

#1135
US20250152772A1
Human necessities

PHOTOPOLYMERISABLE COMPOSITION FOR ADHESIVE FOR BIOLOGICAL TISSUES

#1136
US20250152773A1
Human necessities

COSMETIC PRODUCT CONTAINING STERILE PCL MICROSPHERES

#1137
US20250152774A1
Human necessities

COMPRESSED IMPLANTS FOR SOFT TISSUE REPAIR

#1138
US20250152775A1
Human necessities

PORT-ACCESSIBLE MULTIDIRECTIONAL REINFORCED MINIMALLY INVASIVE COLLAGEN DEVICE FOR SOFT TISSUE REPAIR

#1139
US20250152776A1
Human necessities

CFR-PEEK ORTHOPEDIC IMPLANT AND PREPARATION METHOD THEREFOR, AND WIRELESS SENSING DEVICE

#1140
US20250152777A1
Human necessities

DECELLULARIZED MUSCLE MATRICES AND METHODS FOR MAKING AND USING SAME

#1141
US20250152778A1
Human necessities

NERVE GRAFTS AND METHODS OF PREPARATION THEREOF

#1142
US20250152779A1
Human necessities

NERVE GRAFTS AND METHODS OF PREPARATION THEREOF

#1143
US20250152780A1
Human necessities

METHOD FOR PREPARING BIOLOGICAL VALVE MATERIAL BY MEANS OF DOUBLE-BOND POLYMERIZATION AFTER ALDEHYDE CROSSLINKING, AS WELL AS BIOLOGICAL VALVE MATERIAL AND USE

#1144
US20250152781A1
Human necessities

TISSUE ENGINEERING AND DRUG DELIVERY DEVICE

#1145
US20250152782A1
Human necessities

DISPOSABLE SYSTEM AND METHOD FOR PREPARING A COMPRESSED HYDROGEL

#1146
US20250152783A1
Human necessities

INTERMITTENT URINARY CATHETER HAVING MULTIPLE DRAINAGE OPENINGS

#1147
US20250152784A1
Human necessities

Fluoropolymer Based Anti-Thrombotic Coatings

#1148
US20250152785A1
Human necessities

OSTEOSYNTHESIS SYSTEM WITH BONE PLATE AND BONE ANCHOR MADE OF MAGNESIUM ALLOYS

#1149
US20250152786A1
Chemistry; metallurgy

HIGHLY CONDUCTIVE TISSUE-LIKE HYDROGEL ADHESIVE FOR BIOELECTRONICS AND MANUFACTURING THEREOF

#1150
US20250152787A1
Human necessities

MEDICAL DEVICES COATED WITH SHAPE MEMORY POLYMER FOAMS

#1151
US20250152788A1
Human necessities

Bone Marrow Adipose Portion Isolation Methods

#1152
US20250152789A1
Human necessities

SCREEN EXCHANGE DEVICE, BIOLOGICAL TISSUE SIZE REDUCTION SYSTEM COMPRISING SAME, BIOLOGICAL TISSUE SIZE REDUCTION METHOD USING SAME, AND METHOD FOR SEPARATING TARGET SUBSTANCE FROM RELEVANT BIOLOGICAL TISSUE

#1153
US20250152790A1
Human necessities

INDEPENDENTLY-CONTROLLED TWO-SIDED BREAST PUMP

#1154
US20250152791A1
Human necessities

Connector and breast pump with the same

#1155
US20250152792A1
Human necessities

DIALYSIS SYSTEM AND METHODS

#1156
US20250152793A1
Human necessities

PHASED CONVECTIVE OPERATION

#1157
US20250152794A1
Human necessities

CONTROL OF A MACHINE FOR PERITONEAL DIALYSIS

#1158
US20250152795A1
Human necessities

APPARATUS FOR EXTRACORPOREAL BLOOD TREATMENT

#1159
US20250152796A1
Human necessities

HEART LUNG MACHINE WITH CONTROL ASSEMBLY

#1160
US20250152797A1
Human necessities

APPARATUS FOR THE EXTRACORPOREAL TREATMENT OF BLOOD

#1161
US20250152798A1
Human necessities

Autonomous Waste Collection Assembly and Medical Waste Collection System and Methods

#1162
US20250152799A1
Human necessities

SENSING CANNULA SYSTEMS

#1163
US20250152800A1
Human necessities

NEGATIVE PRESSURE WOUND THERAPY APPARATUSES AND METHODS FOR USING THE SAME

#1164
US20250152801A1
Human necessities

CANISTER STATUS DETECTION IN WOUND FOR PRESSURE THERAPY SYSTEMS

#1165
US20250152802A1
Human necessities

MEDICAL DEVICES WITH A NEGATIVE PRESSURE SOURCE AND RELATED SYSTEMS AND METHODS OF USE

#1166
US20250152803A1
Human necessities

WOUND DRESSING

#1167
US20250152804A1
Human necessities

SYSTEMS AND METHODS FOR OPERATING NEGATIVE PRESSURE WOUND THERAPY DEVICES

#1168
US20250152805A1
Human necessities

CARTON

#1169
US20250152806A1
Human necessities

RADIOPHARMACEUTICAL DELIVERY SYSTEM FOR PATIENT INFUSION

#1170
US20250152807A1
Human necessities

AUTOMATED INSERTION ASSEMBLY

#1171
US20250152808A1
Human necessities

DEVICE FOR DELIVERING INSULIN WITH BASEPLATE AND INTEGRATED MEMS MICROPUMP AND PRESSURE SENSOR

#1172
US20250152809A1
Human necessities

SYSTEM AND METHOD FOR INSULIN PUMP MEDICAL DEVICE INCLUDING A SLIDER ASSEMBLY WHEREIN IMAGES ON DISPLAY ALLOW FOR HIGHLIGHTING AND MAGNIFYING IMAGES

#1173
US20250152810A1
Human necessities

PATCH-SIZED FLUID DELIVERY SYSTEMS AND METHODS

#1174
US20250152811A1
Human necessities

IMPLANTABLE MEDICAL DEVICES THAT DETECT INADVERTENT DELIVERY OF DRUG TO A SUBCUTANEOUS POCKET

#1175
US20250152812A1
Human necessities

INFUSION PUMP ASSEMBLY

#1176
US20250152813A1
Human necessities

FLUID INJECTOR SYSTEM, METHOD OF PREVENTING FLUID BACKFLOW, AND COMPUTER PROGRAM PRODUCT

#1177
US20250152814A1
Human necessities

DIABETES THERAPY BASED ON DETERMINATION OF FOOD ITEM

#1178
US20250152815A1
Human necessities

PATIENT CARE SYSTEM FOR CRITICAL MEDICATIONS

#1179
US20250152816A1
Human necessities

INTEGRATED INSULIN DELIVERY SYSTEM WITH CONTINUOUS GLUCOSE SENSOR

#1180
US20250152817A1
Human necessities

TIME AVERAGED BASAL RATE OPTIMIZER

#1181
US20250152818A1
Human necessities

AUTO-INJECTOR AND RELATED METHODS OF USE

#1182
US20250152819A1
Human necessities

AUTO-INJECTOR

#1183
US20250152820A1
Human necessities

AUTO-INJECTOR

#1184
US20250152821A1
Human necessities

AUTO-INJECTOR

#1185
US20250152822A1
Human necessities

AUTO-INJECTOR

#1186
US20250152823A1
Human necessities

AUTO-INJECTOR

#1187
US20250152824A1
Human necessities

MEDICAMENT DELIVERY DEVICES FOR ADMINISTRATION OF A MEDICAMENT WITHIN A PREFILLED SYRINGE

#1188
US20250152825A1
Human necessities

Auto-Injector

#1189
US20250152826A1
Human necessities

Auto-Injector

#1190
US20250152827A1
Human necessities

Auto-Injector

#1191 ✅ Patent 12,337,148 granted on 2025-06-24
US20250152828A1
Human necessities

Auto-Injector

#1192
US20250152829A1
Human necessities

SUB-ASSEMBLY WITH FEEDBACK FOR A MEDICAMENT DELIVERY DEVICE

#1193
US20250152830A1
Human necessities

SMART INJECTION SYSTEM

#1194
US20250152831A1
Human necessities

AUTO INJECTOR WITH ADAPTABLE AIR-SHOT MECHANISM

#1195
US20250152832A1
Human necessities

DEVICES AND METHODS FOR PRECISION DOSE DELIVERY

#1196
US20250152833A1
Human necessities

SYRINGE AND GASKET SYSTEMS

#1197
US20250152834A1
Human necessities

DOSE DETECTION SYSTEM MODULE FOR A MEDICATION DELIVERY DEVICE

#1198
US20250152835A1
Human necessities

DOSE DELIVERY DEVICE WITH MODIFIED DECOUPLING CLUTCH

#1199
US20250152836A1
Human necessities

A sub-assembly for a medicament delivery device

#1200
US20250152837A1
Human necessities

Drug Delivery Device